Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00316
Species: Homo sapiens
Position : chr19:1109765-1110214
Year: 2023
Title: Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: neuroblastoma
PMID:  36889906
MONDO: MONDO:0005070
Tissue: Adrenal gland
Tissue Ontology ID: UBERON:0002369
Cell Source: CHLA10
CVCL ID: CVCL_6583
Cell Type: neuroblastoma cell
Cell Ontology ID: CL:0000031
Experiment Type: Enhancer activity assay, Chromatin interaction assay, Functional perturbation assay
High Throughput Method: ChIP-seq, ATAC-seq, HiChIP, leChRO-seq
Low Throughput Method: CRISPR knockout, 4C-seq, RT-RT-qPCR
About Target Gene
Target gene : GPX4
About TF
TF name : JUND
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
JUND AP-1 transcription factor network pid 71
JUND ATF-2 transcription factor network pid 59
JUND EGFR1 netpath 475
JUND Inflammation mediated by chemokine and cytokine signaling pathway panther 189
JUND PDGFR-beta signaling pathway pid 125
JUND TGF-beta signaling pathway panther 88
JUND TGF_beta_Receptor netpath 220
JUND Validated transcriptional targets of AP1 family members Fra1 and Fra2 pid 37
JUND MAPK signaling pathway kegg 264
JUND Hs_Apoptosis-related_network_due_to_altered_Notch3_in_ovarian_cancer_WP2864_79278 wikipathways 51
JUND Hs_VEGFA-VEGFR2_Signaling_Pathway_WP3888_90000 wikipathways 153
JUND Hs_Oncostatin_M_Signaling_Pathway_WP2374_73668 wikipathways 44
JUND Hs_EGF-EGFR_Signaling_Pathway_WP437_79266 wikipathways 107
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_00315 chr19:1109765-1110214 Bone Ewing sarcoma cell Ewing sarcoma
Expression of Target Genes for the Enhancer